The University of Kentucky Markey Cancer Center is an academic, clinical and research center located in Lexington, Kentucky. It was established in 1985, and has grown to 28 departments across eight colleges.

During the past decade, Lucille Parker Markey Cancer Center, University of Kentucky conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lucille Parker Markey Cancer Center, University of Kentucky" #1 sponsor was "NSABP Foundation Inc" with 4 trials, followed by "Theradex" with 2 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "NCIC Clinical Trials Group" with 1 trials sponsored and "Prologue Research International" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lucille Parker Markey Cancer Center, University of Kentucky" #1 collaborator was "National Cancer Institute (NCI)" with 6 trials as a collaborator and "NCIC Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Lucille Parker Markey Cancer Center, University of Kentucky" are "Breast Cancer" (4 trials), "Colorectal Cancer" (2 trials), "Kidney Cancer" (1 trials), "Leukemia" (1 trials) and "Myelodysplastic Syndromes" (1 trials). Many other conditions were trialed in "Lucille Parker Markey Cancer Center, University of Kentucky" in a lesser frequency.

Most popular intervention types in "Lucille Parker Markey Cancer Center, University of Kentucky" are "Drug" (10 trials), "Procedure" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (3 trials), "DHA-paclitaxel" (2 trials), "Adriamycin" (1 trials), "Cyclophosphamide" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lucille Parker Markey Cancer Center, University of Kentucky" are 5 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Lucille Parker Markey Cancer Center, University of Kentucky". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Lucille Parker Markey Cancer Center, University of Kentucky, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Lucille Parker Markey Cancer Center, University of Kentucky, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".